Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sagittarius Life ScienceROCO:3205 48 Net Debt Paydown Yield % is 0.28% as of Jul. 25, 2026, which is 300% above its 10-year median of 0.07. GuruFocus rates ROCO:3205 with a GF Score™ of 48/100 and a GF Value™ of NT$17.85 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,162 Biotechnology companies, Sagittarius Life Science ranks better than 62.56% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Sagittarius Life Science's Net Debt Paydown Yield % was 0.28%.
Sagittarius Life Science (ROCO:3205) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
Sagittarius Life Science Net Debt Paydown Yield % Related Terms
Sagittarius Life Science Net Debt Paydown Yield % Historical Data
* Premium members only.
The historical data trend for Sagittarius Life Science's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sagittarius Life Science Net Debt Paydown Yield % Chart
ROCO:3205 vs VRTX, REGN, ALNY: Net Debt Paydown Yield % Comparison
For the Biotechnology subindustry, Sagittarius Life Science's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sagittarius Life Science Net Debt Paydown Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sagittarius Life Science's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Sagittarius Life Science's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of 0.28% mean?
Sagittarius Life Science (ROCO:3205) has a Net Debt Paydown Yield % of 0.28% as of Jul. 25, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Sagittarius Life Science and its competitors. This is 300% above median its historical median of 0.07. According to the industry distribution chart, Sagittarius Life Science ranks #435 out of 1162 companies in the Biotechnology industry, placing it in the top 37.4%.
Is Sagittarius Life Science's Net Debt Paydown Yield % too high?
Sagittarius Life Science's current Net Debt Paydown Yield % of 0.28% is 300% above median its 10-year median of 0.07. The Biotechnology industry median Net Debt Paydown Yield % is 0.03. Sagittarius Life Science's value of 0.28% is 833.3% above this industry median. Based on the distribution chart, Sagittarius Life Science ranks #435 out of 1162 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sagittarius Life Science has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sagittarius Life Science's Net Debt Paydown Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sagittarius Life Science ranks #435 out of 1162 companies for Net Debt Paydown Yield %. This puts Sagittarius Life Science in the upper half of its industry. The industry median Net Debt Paydown Yield % is 0.03. Sagittarius Life Science's value of 0.28% is 833.3% above this benchmark. While the company's 10-year median is 0.07 vs. the industry median of 0.03, Sagittarius Life Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Biotechnology company?
The median Net Debt Paydown Yield % among Biotechnology companies is 0.03, based on 1,162 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sagittarius Life Science's current Net Debt Paydown Yield % of 0.28% is 833.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Sagittarius Life Science and its competitors. For the Biotechnology industry, the median Net Debt Paydown Yield % is 0.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sagittarius Life Science's current Net Debt Paydown Yield % is 0.28%, which is 300% above median its own 10-year median of 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sagittarius Life Science stock overvalued right now?
Based on GuruFocus' analysis, Sagittarius Life Science (ROCO:3205) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$17.85, compared to a current price of NT$50.00 — trading 180.1% above its estimated fair value. The current Net Debt Paydown Yield % is 0.28%, which is 300% above median its 10-year median of 0.07 and 833.3% above the Biotechnology industry median of 0.03. Sagittarius Life Science's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Sagittarius Life Science (ROCO:3205), the current Net Debt Paydown Yield % is 0.28% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sagittarius Life Science (ROCO:3205) Overvalued in 2026?
Based on GuruFocus' analysis, Sagittarius Life Science stock appears to be overvalued.
The current stock price of NT$50.00 is trading 180.1% above its estimated GF Value™ of NT$17.85.
GuruFocus considers Sagittarius Life Science to be Significantly Overvalued.
Key valuation signals for ROCO:3205:
Net Debt Paydown Yield %: 0.28% (300% above median its 10-year median of 0.07)
GF Value™: NT$17.85 vs. price of NT$50.00 (180.1% above fair value)
Industry Position: 833.3% above the Biotechnology median (#435 of 1162)
No single metric tells the full story. See the ROCO:3205 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sagittarius Life Science Corp is a Taiwan-based company engaged in the biotechnology and pharmaceutical sectors. The segment includes: Food and Others, with the majority of revenue from Food.
48GF Score
Get the complete analysis for ROCO:3205
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:3205 has been successfully added to your 
